[Congressional Record Volume 167, Number 91 (Tuesday, May 25, 2021)]
[Senate]
[Pages S3451-S3452]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2011. Mr. HAGERTY submitted an amendment intended to be proposed 
to amendment SA 1502 proposed by Mr. Schumer to the bill S. 1260, to 
establish a new Directorate for Technology and Innovation in the 
National Science Foundation, to establish a regional technology hub 
program, to require a strategy and report on economic security, 
science, research, innovation, manufacturing, and job creation, to 
establish a critical supply chain resiliency program, and for other 
purposes; which was ordered to lie on the table; as follows:

       In section 3291I(c), strike ``a written report'' and all 
     that follows through ``detailing a description'' and insert 
     the following: ``an unclassified written report, with a 
     classified annex, that includes--
       (1) a description
       In section 3291I, amend subsection (e) to read as follows:

[[Page S3452]]

       (e) Report on Drug Seizures.--Not later than 6 months after 
     the date of the enactment of this Act, and annually 
     thereafter, the Administrator of the Drug Enforcement 
     Administration, in coordination with the Office of National 
     Drug Control Policy, U.S. Customs and Border Protection, the 
     Department of Homeland Security, the Department of Justice, 
     the Coast Guard, the Centers for Disease Control and 
     Prevention, the Office of the United States Trade 
     Representative, the Office of the Director of National 
     Intelligence, the Central Intelligence Agency , the 
     Department of Defense, the United States Postal Service, and 
     other relevant agencies, shall submit a report to Congress 
     that describes--
       (1) with respect to illicit fentanyl, fentanyl analogues, 
     synthetic opioids, the precursors for illicit fentanyl, 
     fentanyl analogues, or synthetic opioids, methamphetamine, or 
     methamphetamine precursors seized at the United States 
     borders and ports of entry--
       (A) the source countries from which such drugs originated 
     and the third party countries through which such drugs 
     traveled;
       (B) the amounts of illicit fentanyl, fentanyl analogues, 
     synthetic opioids, the precursors for illicit fentanyl, 
     fentanyl analogues, or synthetic opioids, methamphetamine, or 
     methamphetamine precursors; and
       (C) the lethality of the amounts of illicit fentanyl, 
     fentanyl analogues, synthetic opioids, the precursors for 
     illicit fentanyl, fentanyl analogues, or synthetic opioids, 
     methamphetamine, or methamphetamine precursors seized;
       (2) with respect to illicit fentanyl, fentanyl analogues, 
     synthetic opioids, the precursors for illicit fentanyl, 
     fentanyl analogues, or synthetic opioids, methamphetamine, or 
     methamphetamine precursors seized within the United States--
       (A) the source countries from which such drugs originated 
     and the third party countries through which such drugs 
     traveled;
       (B) the amounts of illicit fentanyl, fentanyl analogues, 
     synthetic opioids, the precursors for illicit fentanyl, 
     fentanyl analogues, or synthetic opioids, methamphetamine, or 
     methamphetamine precursors seized; and
       (C) the lethality of the amounts of illicit fentanyl, 
     fentanyl analogues, synthetic opioids, the precursors for 
     illicit fentanyl, fentanyl analogues, or synthetic opioids, 
     methamphetamine, or methamphetamine precursors seized; and
       (3) the activities conducted by Chinese entities and 
     nationals in furtherance of illicit fentanyl production in 
     Mexico for drug trafficking purposes.
                                 ______